🔎 Trials Near Me

Dachaigh › Lymphoma › Connecticut › New Haven

Sgrùdaidhean clionaigeach Lymphoma ann an New Haven, CT

Tha 7 sgrùdaidhean airson Lymphoma a’ lorg phàirtichean aig làraichean ann agus timcheall air New Haven (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

A’ fastadhÌre 3
  • Yale Cancer Center, New Haven
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06084936

DALY II USA/ MB-CART2019.1 for DLBCL

A’ fastadhÌre 2
  • Yale University, New Haven
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Iuch 2026 · NCT04792489

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

A’ fastadhÌre 1
  • Yale New Haven Hospital, New Haven
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT07465835

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

A’ fastadhÌre 1
  • Yale Cancer Center, New Haven
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT05131022

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

A’ fastadhÌre 1/2
  • Dren Investigational Site, New Haven
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

A’ fastadhSgrùdadh amharc
  • Yale University, New Haven
Gach aois · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT01790152

Sgrùdaidhean Lymphoma ann am bailtean eile

Sgrùdaidhean eile ann an New Haven

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.